Health Advocacy
NEWHow WikiLeaks Is Changing The Face
Of Journalism
Jane Bryant
The One Click Group NEW
Courage Is Contagious
How To Whistleblow Safely
Julian Assange
WikiLeaks One Click Launches
Support
Dr Sarah Myhill
Campaign
By Jane Bryant Digital Economy Bill
Threatens One Click
By Jane Bryant UPDATED
March 2010
One Click
Freedom
Of Information
UK Police Harassment
In The Internet Era Barbara Loe Fisher
Interview
NVIC Conference
Style, Gonads
Brass Ovaries
By Jane Bryant New Journalism
Challenging
Status Quo
By Jane Bryant
NVIC Conference
USA How The
Judicial Review
Of The CFS/ME
NICE Guidelines
Was Lost
Jane Bryant
The One Click Group The BMJ
Vaccines Propaganda
Professor
David Salisbury
And
Trimedia
Public Relations David Southall
"A Very
Dangerous Doctor"
Panorama swims
with sharks
Lisa Blakemore Brown Dr David Salisbury
Ooops!
Never Mind Me,
I'm Basil Fawlty! ONE CLICK RESPONSE
David Salisbury
Vaccine Litigation Biomedical Test
For ME/CFS Announced
Dr Sarah Myhill
MB BS The Politics
And Commerce
Of Autism
By Lisa Blakemore Brown
Psychologist Poling
Vaccine/Autism Case
Mitochondrial Disfunction
ME/CFS Patients One Click Response
NICE Guidelines One Click Report
Gibson Inquiry How To Solve A Problem Like ME/CFS:
Why The Gibson Report Has Failed Patients Realpolitik and ME
By Martin J. Walker The Consensus Report
Family Law Reform Canadian Definition of ME-CFS The Weird World of Wikipedia
By Martin J. Walker Click here to email us your opinions.
| [Previous] | [Next] |
| [Previous] | [Next] |
| ADHD Children With Heart Conditions Die On Ritalin | ||
| Reuters Group urges heart test before kids get ADHD drugs Mon Apr 21, 2008 By Will Dunham WASHINGTON (Reuters) - Children with attention deficit hyperactivity disorder should get their hearts checked before starting treatment with Ritalin or other stimulant drugs, experts recommended on Monday. The American Heart Association called for these children to undergo an electrocardiogram, a test that detects and records the heart's electrical activity, before taking such drugs. The group said it is not clear that these medications increase a child's risk of sudden cardiac death, but issued the new recommendations out of an abundance of caution. "There's been concern that these drugs might be associated in a very small number of individuals' sudden cardiac arrest or sudden cardiac death," said Dr. Victoria Vetter of the University of Pennsylvania School of Medicine in Philadelphia, who led the panel that drafted the recommendations. "There's no registry in the country to determine how many young people are dying from sudden cardiac arrest and what they might have causing that -- and similarly how many of those who die might be on these medications. So there's no causal information," Vetter added in a telephone interview. Ritalin, Novartis AG's brand name for the generic drug methylphenidate, is a central nervous system stimulant prescribed to calm and focus children with ADHD, a condition marked by inattention, hyperactivity and impulsive behavior. ADHD appears to be more common in children with heart conditions, the American Heart Association said in the recommendations, published in its journal Circulation. The group said U.S. Food and Drug Association data showed that between 1999 and 2004, 19 children taking ADHD drugs died suddenly and 26 children had cardiovascular events such as strokes, cardiac arrests and heart palpitations. MILLIONS TREATED Millions of U.S. children are taking ADHD drugs. Research has indicated that stimulants like Ritalin can raise the heart rate and blood pressure. While these side effects are unimportant for most children with ADHD, they can be relevant for those with a heart condition, the American Heart Association said. Some heart conditions can raise the risk for sudden cardiac death, which can happen when heart rhythm becomes erratic. The association's recommendations call for a child to get an electrocardiogram before starting ADHD stimulant medications because the test may identify conditions like heart rhythm abnormalities that can trigger sudden cardiac death. "It won't pick up every one. There will be some false positives. But it's a relatively inexpensive and simple test that doesn't hurt the children in any way and it will let us identify some of these children and know that they have heart conditions," Vetter said. "We particularly don't want to scare people or to alarm them," Vetter said. The group also urged doctors to evaluate the heart health of children already taking ADHD medications if they were not evaluated before they began treatment. If the electrocardiogram turns up trouble, that does not necessarily mean the child should not get ADHD medications, Vetter said. "We would monitor those children more carefully -- start them on lower doses of drugs and see how they do," she said. Two U.S. health agencies said last year they were launching a two-year assessment of potential heart risks from ADHD drugs. (Editing by Maggie Fox and Philip Barbara) |
||
|
||
